MSCs from Amniotic Membrane

MSCs from Amniotic Membrane for Primary Immunodeficiency

How Stem Plus applies MSCs from Amniotic Membrane within a personalised Primary Immunodeficiency protocol — in the EU, from €3,000–€8,000.

For Primary Immunodeficiency, MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for Primary Immunodeficiency. Compare them on the Primary Immunodeficiency overview, or see the MSCs from Amniotic Membrane page.

Educational information; investigational for several conditions. Outcomes vary.

Zelltherapie auf EU-Niveau – ohne westeuropäische Preise.

GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.

Kostenlose ärztliche Prüfung